A single-arm, phase II study of sotorasib plus carboplatin/pemetrexed in advanced non-squamous non-small cell lung cancer patients with KRAS G12C mutation (WJOG14821L, SCARLET).
Akamatsu H, Sakata S, Azuma K, Yoshioka H, Uemura T, Tsuchiya-Kawano Y, Esumi S, Kurosaki T, Sato Y, Sakamoto T, Ninomiya K, Toyozawa R, Yoneshima Y, Shukuya T, Kozuki T, Watanabe K, Daga H, Kato T, Takahashi T, Osuga M, Koh Y, Morita S, Yamamoto N.
Akamatsu H, et al. Among authors: sato y.
J Thorac Oncol. 2025 Jan 17:S1556-0864(25)00007-3. doi: 10.1016/j.jtho.2025.01.006. Online ahead of print.
J Thorac Oncol. 2025.
PMID: 39828218